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radicating polio - Building the boat while sailing
. John
Christian Medical College, Vellore, India
In 2012 we are at a peculiar juncture of polio eradication.
here are sufﬁcient reasons for optimism, but there are also many
nknowns ahead. Wild poliovirus (WPV) type 2 was eradicated
n 1999, providing proof of principle that WPV 1 and 3 can also
e eradicated. Only in parts of 3 countries, Nigeria, Pakistan and
fghanistan, WPV 1 and 3 transmissions have not yet been inter-
upted.
The exclusive use of trivalent OPV (tOPV) had some justiﬁ-
ations but also major problems not exactly unpredicted. OPV
as wide geographic variations of efﬁcacy and inherent geno-
ypic/phenotypic tendency to de-attenuate. Where WPV 1 and 3
ransmissions were intense in infancy, the efﬁcacy of types 1 and 3
n tOPVwas particularly low. Since 2005monovalent OPVs (mOPV-
and3)with superior efﬁcacy are in use, overcoming the inhibitory
ffect of type 2 vaccine virus. In 2009, a bivalent OPV (bOPV) con-
aining type 1 and 3 was tested and found non-inferior to mOPVs.
ince then bOPV is widely used. Many doubt if WPV 1 or 3 could
ave been eradicated with tOPV.
For 12 years type 2 vaccine virus was fed to children although
PV 2 was eradicated. Since vaccine viruses cause polio as an
dverse reaction (vaccine-associated paralytic polio, VAPP), an eth-
cal dilemma emerged: type 2 VAPP while there is no type 2 WPV
olio. Moreover, de-attenuated vaccine viruses with genotypic and
henotypic properties of neuro-virulence and easy transmissibil-
ty – called ‘vaccine-derived polioviruses’ (VDPVs) have emerged
n many locations where OPV is being used. Post-WPV eradication
PV must be discontinued to stop VAPP, but then silent transmis-
ions of VDPVs will ﬂare up, capturing the niche left by WPVs. True
olio eradicationmust be deﬁned as zero infectionworldwidewith
ild and vaccine viruses.
The availability of bOPV presents the opportunity to use it
nstead of tOPV – thus avoiding seeding of vaccine type 2 virus
ny more in the community. However, VDPV-2 circulation must be
nticipated; to preempt and intercept it immunity umbrella with
nactivated poliovaccine (IPV)must be established before replacing
OPVwith bOPV. Once that tactic is found successful, theworldwill
e ready to stop all OPV after global eradication (and certiﬁcation)
f WPV 1 and 3.
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Vaccination programs in Southeast Asia
U. Thisyakorn
Chulalongkorn University, Bangkok, Thailand
Southeast Asia is one of the most densely populated areas
around the world and suffers from large disease burdens of
commonpediatric infectious diseases includingdiarrhea andpneu-
monia. The national vaccination programs and vaccine uptake
of conventional vaccines in this area showed that children in
most countries were well protected from conventional vaccine-
preventable diseases. Differences in vaccine antigens that were
used and variations in time schedules for certain vaccines existed.
Protection against newly developed vaccines such as rotavirus,
pneumococcus and human papillomavirus infections were obvi-
ously inadequate in most of the countries in this area. Children in
Southeast Asia are still suffering from certain vaccine-preventable
diseases. Promoting coverage of newly developed vaccines will
beneﬁt a great number of children in this area. Strengthening of
vaccination for special groups such as adults, health care work-
ers, immunocompromised hosts, pregnant women and travelers is
urgently needed.
Vaccines are unquestionably one of the most cost-effective
public health measures available, yet they are undervalued and
under-utilised throughout the world. It is important for interna-
tional agencies, governments, and health policy makers to keep
this preventive measure in the spotlight. Ultimately, it is the global
society and future generations that beneﬁtwhenall countriesmake
the effort to protect their population fromvaccine-preventable dis-
eases.
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Facing anti-vaccine movements: Myths and facts about adverse
events
K. Powell
Children’s Hospital Medical Center of Akron Department of Pediatrics,
Akron, OH, USA
Anti-vaccine movements are motivated variously by political,
cultural, and/or personal factors. Three tactics used by anti-vaccine
activists are 1) creating doubt about vaccine safety, 2) insistence on
the individual’s right to decide about vaccination, and 3) requiring
that research be done to address the activists’ concerns. Examples
of anti-vaccine activities illustrate these points.
A paper by Wakeﬁeld, published in the UK in1998 and subse-
quently retracted, claimed that autism was caused by the MMR
